Pancreatic Cancer Research

ResearcherChina Medical UniversityNo recent work listed

Chenghai Zhao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 9 November 2026

Matched on ORCID iD 0000-0003-2246-1425; OpenAlex author ID A5071949256. Sources: OpenAlex.

Their work

Papers
4 (first author 2, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
4
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 2 papers

Papers 4

  1. Fzd7/Wnt7b signaling contributes to stemness and chemoresistance in pancreatic cancer. Last author DOI 10.1002/cam4.3819↗
  2. Regulation of ABCG2 expression by Wnt5a through FZD7 in human pancreatic cancer cells. Last author DOI 10.3892/mmr.2020.11690↗
  3. Significant association between GSTT1 null genotype and susceptibility to pancreatic cancer. First author DOI 10.1007/s11033-013-2516-4↗
  4. Involvement of COX-2/PGE(2) Pathway in the Upregulation of MMP-9 Expression in Pancreatic Cancer. First author DOI 10.1155/2011/214269↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yuanhong Xu · 2 shared papers, 2021 · strength 0.41
  2. Zhongbo Zhang · 2 shared papers, 2021 · strength 0.41
  3. Xianmin Bu · 2 shared papers, 2011–2013 · strength 0.12
  4. Xian-Wei Dai · 1 shared paper, 2011 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.